Dermatology and Allergy

Medicine & Life Sciences

1. Hypersensitivity 100%
2. Psoriasis 88%
3. Atopic Dermatitis 72%
4. Eczema 49%
5. Asthma 46%
6. Allergens 46%
7. Skin 41%
8. filaggrin 38%
9. Child 33%
10. Denmark 32%
11. Patch Tests 31%
12. Odorants 31%
13. Nickel 29%
14. Allergic Contact Dermatitis 28%
15. Contact Dermatitis 27%
16. Dermatitis 26%
17. Hand 24%
18. Cohort Studies 23%
19. Population 18%
20. Systematic Reviews 17%
21. Anaphylaxis 16%
22. Psoriatic Arthritis 16%
23. Meta-Analysis 15%
24. Therapeutics 15%
25. Immunoglobulin E 15%
26. Confidence Intervals 14%
27. Cosmetics 14%
28. 2-methyl-4-isothiazolin-3-one 14%
29. Multiple Chemical Sensitivity 13%
30. Perfume 12%
31. Skin Diseases 12%
32. Cobalt 11%
33. Hair Dyes 11%
34. Adrenal Cortex Hormones 11%
35. Loss of Function Mutation 11%
36. Parturition 11%
37. Metals 11%
38. Quality of Life 10%
39. Placebos 10%
40. Rosacea 10%
41. Occupational Dermatitis 10%
42. Incidence 10%
43. Immunologic Desensitization 10%
44. Allergic Rhinitis 10%
45. Odds Ratio 10%
46. Mast Cells 10%
47. Dermatology 9%
48. Chromium 9%
49. Lung 9%
50. Pharmaceutical Preparations 9%
51. Budesonide 9%
52. Interleukin-17 9%
53. Safety 9%
54. Mutation 9%
55. Genes 8%
56. T-Lymphocytes 8%
57. Biological Products 8%
58. 4-phenylenediamine 8%
59. Registries 8%
60. Chlorhexidine 8%
61. Inflammation 8%
62. Rhinitis 7%
63. Pediatrics 7%
64. Histamine 7%
65. Food Hypersensitivity 7%
66. Mothers 7%
67. Basophils 7%
68. ixekizumab 7%
69. Guidelines 6%
70. Allergy and Immunology 6%
71. Randomized Controlled Trials 6%
72. Skin Tests 6%
73. Comorbidity 6%
74. Biomarkers 6%
75. Cytokines 6%
76. Vaccination 6%
77. isoeugenol 6%
78. Dermatologists 6%
79. Pollen 6%
80. Irritants 6%
81. Deodorants 6%
82. Respiratory Sounds 6%
83. Microbiota 5%
84. Prospective Studies 5%
85. montelukast 5%
86. Cardiovascular Diseases 5%
87. Pregnancy 5%
88. Cross-Sectional Studies 5%
89. Immunotherapy 5%
90. Case-Control Studies 5%
91. Capsaicin 5%
92. Drug Hypersensitivity 5%
93. hydroxyisohexyl 3-cyclohexene carboxaldehyde 5%
94. 5-chloro-2-methyl-4-isothiazolin-3-one 5%
95. Histamine Release 5%
96. secukinumab 5%
97. Ustekinumab 5%
98. Delivery of Health Care 5%